CDEK
← All organizations

Corixa

For profitContributed to NME

Also known as: Corixa Corporation

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 1998

First marketed drug

Jun 27, 2003

First NDA

Jun 27, 2003

Last known activity

Sep 1, 2004

Acquired by GlaxoSmithKline on Jan 1, 2005

Timeline

1990s

  1. Jan 1, 1994

    Corixa— Founded

  2. Jan 1, 1998

    GenQuest, Inc— Acquired

  3. Jan 1, 1999

    Ribi Immunochem— Acquired

2000s

  1. Jan 1, 2000

    Coulter Pharmaceutical— Acquired

  2. Jun 27, 2003

    tositumomab— NDA Organization

  3. Jan 1, 2005

    GlaxoSmithKline— Acquired By

Drugs by trial phase (13 distinct, 11 trials)

Phase 3 (1 own, 1 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (10)

Details

Founded
Seattle, WA, US Jan 1, 1994
First NDA
Jun 27, 2003
Last known activity
Sep 1, 2004

Designations held

  • Orphan drug